Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Drugs for the treatment of metabolic bone diseases.

× No keyword cloud information.

23 in total

Review 1. Therapeutic advances for blocking heterotopic ossification in fibrodysplasia ossificans progressiva.

Authors: Kelly L Wentworth; Umesh Masharani; Edward C Hsiao
Journal: Br J Clin Pharmacol Date: 2019-01-06 Impact factor: 4.335

Review 2. Antiresorptive agents' bone-protective and adjuvant effects in postmenopausal women with early breast cancer.

Authors: Tariq Chukir; Yi Liu; Azeez Farooki
Journal: Br J Clin Pharmacol Date: 2019-01-25 Impact factor: 4.335

Review 3. Regulatory aspects of the development of drugs for metabolic bone diseases - FDA and EMA perspective.

Authors: Theresa Kehoe; Eberhard Blind; Heidi Janssen
Journal: Br J Clin Pharmacol Date: 2018-12-03 Impact factor: 4.335

4. Taxonomy of rare genetic metabolic bone disorders.

Authors: L Masi; D Agnusdei; J Bilezikian; D Chappard; R Chapurlat; L Cianferotti; J-P Devolgelaer; A El Maghraoui; S Ferrari; M K Javaid; J-M Kaufman; U A Liberman; G Lyritis; P Miller; N Napoli; E Roldan; S Papapoulos; N B Watts; M L Brandi
Journal: Osteoporos Int Date: 2015-06-13 Impact factor: 4.507

Review 5. Clinical and translational pharmacology of the cathepsin K inhibitor odanacatib studied for osteoporosis.

Authors: Julie A Stone; Jacqueline B McCrea; Rose Witter; Stefan Zajic; S Aubrey Stoch
Journal: Br J Clin Pharmacol Date: 2019-03-18 Impact factor: 4.335

Review 6. Update on pharmacologically-relevant vitamin D analogues.

Authors: Glenville Jones; Martin Kaufmann
Journal: Br J Clin Pharmacol Date: 2018-11-22 Impact factor: 4.335

Review 7. Pharmacological management of X-linked hypophosphataemia.

Authors: Erik A Imel; Kenneth E White
Journal: Br J Clin Pharmacol Date: 2018-10-29 Impact factor: 4.335

8. Diphosphonates inhibit hydroxyapatite dissolution in vitro and bone resorption in tissue culture and in vivo.

Authors: H Fleisch; R G Russell; M D Francis
Journal: Science Date: 1969-09-19 Impact factor: 47.728

Review 9. Clinical and translational pharmacological aspects of the management of fibrous dysplasia of bone.

Authors: Marlous Rotman; Neveen Agnes Therese Hamdy; Natasha M Appelman-Dijkstra
Journal: Br J Clin Pharmacol Date: 2018-12-25 Impact factor: 4.335

Review 10. Genetic approaches to metabolic bone diseases.

Authors: Fadil M Hannan; Paul J Newey; Michael P Whyte; Rajesh V Thakker
Journal: Br J Clin Pharmacol Date: 2018-11-28 Impact factor: 4.335

1 in total

1. Drugs for the treatment of metabolic bone diseases.

Authors: Matthew T Drake; Serge Cremers; R Graham Russell; John P Bilezikian
Journal: Br J Clin Pharmacol Date: 2019-04-04 Impact factor: 4.335

1 in total